Nephrology And Urology Devices Market Size, Share, and Trends 2025 to 2034

Nephrology And Urology Devices Market (By Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, Others; By Application: Urolithiasis, Urological Cancer & BPH, Bladder Disorders, Kidney Diseases, Others; By End-Use: Hospitals, Clinics, Ambulatory Surgical Centers, Others) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035

Last Updated : 18 Dec 2025  |  Report Code : 2570  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Nephrology and Urology Devices Market 

5.1. COVID-19 Landscape: Nephrology and Urology Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Nephrology and Urology Devices Market, By Product

8.1. Nephrology and Urology Devices Market, by Product

8.1.1 Ureteral Catheters

8.1.1.1. Market Revenue and Forecast

8.1.2. PCN Catheters

8.1.2.1. Market Revenue and Forecast

8.1.3. Urinary Stents

8.1.3.1. Market Revenue and Forecast

8.1.4. Stone Basket

8.1.4.1. Market Revenue and Forecast

8.1.5. Urology Guidewires

8.1.5.1. Market Revenue and Forecast

8.1.6. Renal Dilators

8.1.6.1. Market Revenue and Forecast

8.1.7. Others

8.1.7.1. Market Revenue and Forecast

Chapter 9. Global Nephrology and Urology Devices Market, By Application

9.1. Nephrology and Urology Devices Market, by Application

9.1.1. Urolithiasis

9.1.1.1. Market Revenue and Forecast

9.1.2. Urological Cancer & BPH

9.1.2.1. Market Revenue and Forecast

9.1.3. Bladder Disorders

9.1.3.1. Market Revenue and Forecast

9.1.4. Kidney Diseases

9.1.4.1. Market Revenue and Forecast

9.1.5. Others

9.1.5.1. Market Revenue and Forecast

Chapter 10. Global Nephrology and Urology Devices Market, By End Use 

10.1. Nephrology and Urology Devices Market, by End Use

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast

10.1.2. Clinics

10.1.2.1. Market Revenue and Forecast

10.1.3. Ambulatory Surgical Centers

10.1.3.1. Market Revenue and Forecast

10.1.4. Others

10.1.4.1. Market Revenue and Forecast

Chapter 11. Global Nephrology and Urology Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product

11.1.2. Market Revenue and Forecast, by Application

11.1.3. Market Revenue and Forecast, by End Use

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product

11.1.4.2. Market Revenue and Forecast, by Application

11.1.4.3. Market Revenue and Forecast, by End Use

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product

11.1.5.2. Market Revenue and Forecast, by Application

11.1.5.3. Market Revenue and Forecast, by End Use

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product

11.2.2. Market Revenue and Forecast, by Application

11.2.3. Market Revenue and Forecast, by End Use

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product

11.2.4.2. Market Revenue and Forecast, by Application

11.2.4.3. Market Revenue and Forecast, by End Use

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product

11.2.5.2. Market Revenue and Forecast, by Application

11.2.5.3. Market Revenue and Forecast, by End Use

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product

11.2.6.2. Market Revenue and Forecast, by Application

11.2.6.3. Market Revenue and Forecast, by End Use

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product

11.2.7.2. Market Revenue and Forecast, by Application

11.2.7.3. Market Revenue and Forecast, by End Use

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product

11.3.2. Market Revenue and Forecast, by Application

11.3.3. Market Revenue and Forecast, by End Use

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product

11.3.4.2. Market Revenue and Forecast, by Application

11.3.4.3. Market Revenue and Forecast, by End Use

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product

11.3.5.2. Market Revenue and Forecast, by Application

11.3.5.3. Market Revenue and Forecast, by End Use

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product

11.3.6.2. Market Revenue and Forecast, by Application

11.3.6.3. Market Revenue and Forecast, by End Use

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product

11.3.7.2. Market Revenue and Forecast, by Application

11.3.7.3. Market Revenue and Forecast, by End Use

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product

11.4.2. Market Revenue and Forecast, by Application

11.4.3. Market Revenue and Forecast, by End Use

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product

11.4.4.2. Market Revenue and Forecast, by Application

11.4.4.3. Market Revenue and Forecast, by End Use

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product

11.4.5.2. Market Revenue and Forecast, by Application

11.4.5.3. Market Revenue and Forecast, by End Use

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product

11.4.6.2. Market Revenue and Forecast, by Application

11.4.6.3. Market Revenue and Forecast, by End Use

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product

11.4.7.2. Market Revenue and Forecast, by Application

11.4.7.3. Market Revenue and Forecast, by End Use

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product

11.5.2. Market Revenue and Forecast, by Application

11.5.3. Market Revenue and Forecast, by End Use

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product

11.5.4.2. Market Revenue and Forecast, by Application

11.5.4.3. Market Revenue and Forecast, by End Use

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product

11.5.5.2. Market Revenue and Forecast, by Application

11.5.5.3. Market Revenue and Forecast, by End Use

Chapter 12. Company Profiles

12.1. Hollister Incorporated

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Medtronic

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Coloplast

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Boston Scientific Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. ConvaTec Group

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. B. Braun AG

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Teleflex Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Baxter

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Fresenius Medical Care

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Asahi Kasei Corp.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global nephrology and urology devices market size is accounted at USD 7.43 billion in 2025 and it is expected to reach around USD 14.11 billion by 2035.

The global nephrology and urology devices market is poised to grow at a CAGR of 6.62% from 2026 to 2035.

The major players operating in the nephrology and urology devices market are Hollister Incorporated, Medtronic, Coloplast, Boston Scientific Corporation, ConvaTec Group, B. Braun AG, Teleflex Inc., Baxter, Fresenius Medical Care, Asahi Kasei Corp., Cook Group, C. R. Bard Inc., Terumo Corporation, Nxstage Medical Inc., Nipro Corporation and Others.

The driving factors of the nephrology and urology devices market are the rising rate of diabetes and increasing nephrology & urology illness prevalence.

North America region will lead the global nephrology and urology devices market during the forecast period 2026 to 2035.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client